Payers Ultimately Drive All Behavior In US Healthcare
Fred Turner · We Built Our Own Salesforce in Months. Here's Why We're Cancelling the $600K Contract | Curative CEO · Jul 18, 2026 · at 37:43
Fred Turner, CEO of Curative, outlines the strategic rationale behind pivoting Curative into a health insurance payer rather than acquiring hospitals or primary care clinics.
0:00 / 0:18exact quote · 18.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Everything sort of ends up coming back to the payer. Like, the payer is the one that drives behavior in the US healthcare system. If you are providing the dollars, people will go where the dollars aren't. If you say I'm going to pay for this service, people will go do that service. If you say I'm not going to pay for this, people will stop doing that. And so the payer is the one that's kind of driving things.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Fred Turner
Curative Canceled $600K Salesforce Contract For An Internally Vibe-Coded CRM
“We just recently canceled our Salesforce contract because we have an internal CRM that was vibe coded, that is working better, that is managing our process better, is more integrated into what we're doing. We run our agents inside of it, and no one was using S…”
Curative Is Cutting 80% Of Its Enterprise SaaS Spend This Year
“We're cutting about 80% of our SaaS spend this year.”
Corporate Anthropic Spend Will Reach 2x To 5x Engineer Salaries
“Between maybe two and five X would be the two and five X salary.”
Curative Headcount Will Shrink In Short Term Due To AI
“We're about 650 people now. In five years we'll probably be bigger. In the short term I think we're going to be quite a bit smaller.”
Strategic Investor Pulling Series B Term Sheet Caused Shield's Collapse
“Ended up getting a term sheet from a strategic, large public diagnostic company. Signed the term sheet, did three weeks of work on docs. We were in the second round of docs, and then their CEO killed it because it was too competitive with their core products. …”